Joachim E. Roehr

548 total citations
15 papers, 427 citations indexed

About

Joachim E. Roehr is a scholar working on Molecular Biology, Organic Chemistry and Cellular and Molecular Neuroscience. According to data from OpenAlex, Joachim E. Roehr has authored 15 papers receiving a total of 427 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Molecular Biology, 5 papers in Organic Chemistry and 5 papers in Cellular and Molecular Neuroscience. Recurrent topics in Joachim E. Roehr's work include Receptor Mechanisms and Signaling (5 papers), Electroconvulsive Therapy Studies (3 papers) and Synthesis and biological activity (2 papers). Joachim E. Roehr is often cited by papers focused on Receptor Mechanisms and Signaling (5 papers), Electroconvulsive Therapy Studies (3 papers) and Synthesis and biological activity (2 papers). Joachim E. Roehr collaborates with scholars based in United States and France. Joachim E. Roehr's co-authors include Sathapana Kongsamut, Jiesheng Kang, David Rampe, Xiaoliang Chen, Harold B. Hartman, Lisa L. Kerman, Anthony Sandrasagra, Lei‐Han Tang, Craig P. Smith and Roy Corbett and has published in prestigious journals such as Journal of Medicinal Chemistry, Journal of Pharmacology and Experimental Therapeutics and European Journal of Pharmacology.

In The Last Decade

Joachim E. Roehr

15 papers receiving 393 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Joachim E. Roehr United States 10 205 156 101 92 86 15 427
Ralf Weißhorn Germany 8 281 1.4× 148 0.9× 144 1.4× 60 0.7× 39 0.5× 15 538
Rodolfo Testa Italy 15 280 1.4× 74 0.5× 182 1.8× 64 0.7× 62 0.7× 34 617
Joseph Géczy Belgium 14 110 0.5× 47 0.3× 77 0.8× 54 0.6× 70 0.8× 29 373
Liliane Unger Germany 16 255 1.2× 119 0.8× 251 2.5× 92 1.0× 49 0.6× 24 616
Michio Terai United Kingdom 11 362 1.8× 73 0.5× 240 2.4× 75 0.8× 39 0.5× 24 613
Muhammad Sajjad Shahid United Kingdom 8 152 0.7× 71 0.5× 133 1.3× 25 0.3× 144 1.7× 16 404
Kathryn W. Schenck United States 13 314 1.5× 114 0.7× 238 2.4× 75 0.8× 86 1.0× 25 672
Peter J. Gengo United States 15 570 2.8× 282 1.8× 338 3.3× 79 0.9× 63 0.7× 23 832
Ying‐Jun Cao United States 12 286 1.4× 58 0.4× 249 2.5× 57 0.6× 13 0.2× 20 442
Teodozyi Kolasa United States 10 171 0.8× 17 0.1× 138 1.4× 136 1.5× 114 1.3× 10 553

Countries citing papers authored by Joachim E. Roehr

Since Specialization
Citations

This map shows the geographic impact of Joachim E. Roehr's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Joachim E. Roehr with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Joachim E. Roehr more than expected).

Fields of papers citing papers by Joachim E. Roehr

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Joachim E. Roehr. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Joachim E. Roehr. The network helps show where Joachim E. Roehr may publish in the future.

Co-authorship network of co-authors of Joachim E. Roehr

This figure shows the co-authorship network connecting the top 25 collaborators of Joachim E. Roehr. A scholar is included among the top collaborators of Joachim E. Roehr based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Joachim E. Roehr. Joachim E. Roehr is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Giovanni, Andrew, et al.. (2012). Design and synthesis of D1 agonist/D2 antagonist for treatment of schizophrenia. Bioorganic & Medicinal Chemistry Letters. 23(5). 1498–1501. 4 indexed citations
2.
Kongsamut, Sathapana, Jiesheng Kang, Xiaoliang Chen, Joachim E. Roehr, & David Rampe. (2002). A comparison of the receptor binding and HERG channel affinities for a series of antipsychotic drugs. European Journal of Pharmacology. 450(1). 37–41. 188 indexed citations
3.
Smith, Craig P., Gina M. Bores, Wayne W. Petko, et al.. (1997). Pharmacological Activity and Safety Profile of P10358, a Novel, Orally Active Acetylcholinesterase Inhibitor for Alzheimer’s Disease. Journal of Pharmacology and Experimental Therapeutics. 280(2). 710–720. 35 indexed citations
4.
Smith, Craig P., Roy Corbett, Roger D. Porsolt, et al.. (1997). Anti‐Obsessional and Antidepressant Profile of Besipirdine. CNS Drug Reviews. 3(1). 1–23. 9 indexed citations
5.
SHUTSKE, G. M. & Joachim E. Roehr. (1997). Synthesis of some piperazinylpyrazolo[3,4‐b]pyridines as selective serotonin re‐uptake inhibitors. Journal of Heterocyclic Chemistry. 34(3). 789–795. 12 indexed citations
6.
Smith, Craig P., Roy Corbett, Gina M. Bores, et al.. (1996). Serotonergic activity of HP 184: Does spontaneous release have a role?. Neurochemical Research. 21(5). 575–583. 3 indexed citations
7.
Burgher, Kendra L., Harold B. Hartman, Lisa L. Kerman, et al.. (1996). Structure−Activity Relationships of a Series of Novel (Piperazinylbutyl)thiazolidinone Antipsychotic Agents Related to 3-[4-[4-(6-Fluorobenzo[b]thien-3-yl)-1-piperazinyl]butyl]-2,5,5-trimethyl-4- thiazolidinone Maleate. Journal of Medicinal Chemistry. 39(20). 4044–4057. 29 indexed citations
8.
Szczepanik, A. M., et al.. (1996). Ex vivo studies with iloperidone (HP 873), a potential atypical antipsychotic with dopamine D2/5-hydroxytryptamine2 receptor antagonist activity.. Journal of Pharmacology and Experimental Therapeutics. 278(2). 913–920. 11 indexed citations
9.
Kongsamut, Sathapana, Joachim E. Roehr, Harold B. Hartman, et al.. (1996). Iloperidone binding to human and rat dopamine and 5-HT receptors. European Journal of Pharmacology. 317(2-3). 417–423. 67 indexed citations
10.
Smith, Craig P., Roy Corbett, Mark R. Szewczak, et al.. (1996). Besipirdine (HP 749) reduces schedule-induced polydipsia in rats. Brain Research Bulletin. 41(2). 125–130. 15 indexed citations
11.
Roehr, Joachim E., et al.. (1995). Changes in paroxetine binding in the cerebral cortex of polydipsic rats. European Journal of Pharmacology. 278(1). 75–78. 9 indexed citations
12.
Burgher, Kendra L., et al.. (1994). Benzisoxazole- and Benzisothiazole-3-carboxamides as Potential Atypical Antipsychotic Agents. Journal of Medicinal Chemistry. 37(15). 2308–2314. 28 indexed citations
13.
Smith, Craig P., Wayne W. Petko, Sathapana Kongsamut, et al.. (1994). Mechanisms for the increase in electrically stimulated [3H]norepinephrine release from rat cortical slices by N‐(n‐propyl)‐N‐(4‐pyridinyl)‐1H‐indol‐1‐amine. Drug Development Research. 32(1). 13–18. 13 indexed citations
14.
15.
Hartman, Harold B., et al.. (1988). HP 663: A novel compound for the treatment of glaucoma. Drug Development Research. 12(3-4). 197–209. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026